Abstract
It is now well established that the nervous system and the immune system are connected in a reciprocal manner. A major pathway in the neuroimmune crosstalk is provided by the sympathetic nervous system (SNS). Though this interaction is thought to be predominantly mediated by catecholamines (CA), compelling evidence is now available indicating that neuropeptide Y (NPY), released from sympathetic nerves within immune organs, also exerts profound influence on both cellular and humoral immune functions. NPY interferes with critical immune functions, such as differentiation of T helper cells, monocyte mediator release, natural killer (NK) cell activation, and immune cell redistribution. Additionally, NPY also modulates the outcome of CA induced immune alterations in vitro and in vivo, thereby acting as a neuroimmune cotransmitter. In this chapter, we summarize key findings from the interaction between NPY and immune functions and discuss implications for the clinical situation. In addition, fields of future research on this interesting topic are outlined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787–793
Ahmed AA, Wahbi A, Nordlind K, Kharazmi A, Sundqvist KG, Mutt V, Liden S (1998) In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand J Immunol 48:79–85
Ahmed AA, Wahbi AH, Nordlin K (2001) Neuropeptides modulate a murine monocyte/ macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol Immunotoxicol 23:397–409
Ahmed M, Bjurholm A, Theodorsson E, Schultzberg M, Kreicbergs A (1995) Neuropeptide Y-and vasoactive intestinal polypeptide-like immunoreactivity in adjuvant arthritis: effects of capsaicin treatment. Neuropeptides 29:33–43
Andrade-Mena CE (1997) Inhibition of gamma interferon synthesis by catecholamines. J Neuroimmunol 76:10–14
Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E (1993) Relation between the intra-articular temperature of the temporomandibular joint and the presence of neuropeptide Y-like immunoreactivity in the joint fluid. A clinical study. Acta Odontol Scand 51:1–8
Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E (1995) Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special consideration to rheumatoid arthritis. J Orofac Pain 9:215–225
Arinbjarnarson S, Jonsson T, Steinsson K, Sigfusson A, Jonsson H, Geirsson A, Thorsteinsson J, Valdimarsson H (1997) IgA rheumatoid factor correlates with changes in B and T lymphocyte subsets and disease manifestations in rheumatoid arthritis. J Rheumatol 24:269–274
Arzt E, Pereda MP, Castro CP, Pagotto U, Renner U, Stalla GK (1999) Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 20:71–95
Arzubiaga C, Morrow J, Roberts LJ, Biaggioni I (1991) Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. J Allergy Clin Immunol 87:88–93
Baerwald C, Graefe C, von Wichert P, Krause A (1992) Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J Rheumatol 19:204–210
Baerwald CG, Laufenberg M, Specht T, von Wichert P, Burmester GR, Krause A (1997) Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors. Br J Rheumatol 36:1262–1269
Barbany G, Friedman WJ, Persson H (1991) Lymphocyte-mediated regulation of neurotransmitter gene expression in rat sympathetic ganglia. J Neuroimmunol 32:97–104
Barnea A, Roberts J, Keller P, Word RA (2001) Interleukin-1 beta induces expression of neuropeptide Y in primary astrocyte cultures in a cytokine-specific manner: induction in human but not rat astrocytes. Brain Res 896:137–145
Bedoui S, Kuhlmann S, Nave H, Drube J, Pabst R, von Hörsten S (2001) Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes. J Neuroimmunol 117:125–132
Bedoui S, Lechner S, Gebhardt T, Nave H, Beck-Sickinger AG, Straub RH, Pabst R, von Horsten S (2002) NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J Neuroimmunol 132:25–33
Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Hörsten S (2003a) Contributions of NPY to the neuroimmune crosstalk. J Neuroimmunol 134:1–11
Bedoui S, Miyake S, Lin Y, Miyamoto K, Oki S, Kawamura N, Beck-Sickinger A, Hörsten Sv, Yamamura T (2003) Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: Neuropeptide Y1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol 171:3451–3458
Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M (1996) Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 10:77–91
Bracci-Laudiero L, Aloe L, Stenfors C, Theodorsson E, Lundeberg T (1998) Development of systemic lupus erythematosus in mice is associated with alteration of neuropeptide concentrations in inflamed kidneys and immunoregulatory organs. Neurosci Lett 248:97–100
Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW (1997) Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum 40:5–18
Cavallotti C, Artico M, Cavallotti D (1999) Occurrence of adrenergic nerve fibers and of noradrenaline in thymus gland of juvenile and aged rats. Immunol Lett 70:53–62
Chelmicka-Schorr E, Checinski M, Arnason BG (1988) Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J Neuroimmunol 17:347–350
Chelmicka-Schorr E, Kwasniewski MN, Thomas BE, Arnason BG (1989) The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 25:203–207
Correale J, Mix E, Olsson T, Kostulas V, Fredrikson S, Hojeberg B, Link H (1991) CD5+ B cells and CD4-8-T cells in neuroimmunological diseases. J Neuroimmunol 32:123–132
Correale J, Mix E, Olsson T, Kostulas V, Fredrikson S, Hojeberg B, Link H (1991) CD5+ B cells and CD4-8-T cells in neuroimmunological diseases. J Neuroimmunol 32:123–132
Correale J de Los Milagros Bassani Molinas (2002) Oligoclonal bands and antibody responses in Multiple Sclerosis. J Neurol 249:375–389
Cross LJ, Beck-Sickinger AG, Bienert M, Gaida W, Jung G, Krause E, Ennis M (1996) Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues. Br J Pharmacol 117:325–332
Cunnick JE, Lysle DT, Armfield A, Rabin BS (1988) Shock-induced modulation of lymphocyte responsiveness and natural killer activity: differential mechanisms of induction. Brain Behav Immun 2:102–113
D’Hooge R, De Deyn PP, Verzwijvelen A, De Block J, De Potter WP (1990) Storage and fast transport of noradrenaline, dopamine beta-hydroxylase and neuropeptide Y in dog sciatic nerve axons. Life Sci 47:1851–1859
Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345:340–350
de Boer NK, Ammerlaan WA, Meedendorp B, Kroese FG (1992) CD5 B cells in the rat? Ann NY Acad Sci 651:157–159
de la Fuente M, Bernaez I, Del Rio M, Hernanz A (1993) Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY Involvement of protein kinase C. Immunology 80:259–265
de la Fuente M, Del Rio M, Medina S (2001) Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J Neuroimmunol 116:156–167
de Seze J, Arndt C, Stojkovic T, Ayachi M, Gauvrit JY, Bughin M, Saint MT, Pruvo JP, Hache JC, Vermersch P (2001) Pupillary disturbances in multiple sclerosis: correlation with MRI findings. J Neurol Sci 188:37–41
Downing JE Miyan JA (2000) Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol Today 21:281–289
Dureus P, Louis D, Grant AV, Bilfinger TV, Stefano GB (1993) Neuropeptide Y inhibits human and invertebrate immunocyte chemotaxis, chemokinesis, and spontaneous activation. Cell Mol Neurobiol 13:541–546
Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Hakanson R, Sundler F (1984) Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 8:225–235
Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000) The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52:595–638
Elitsur Y, Luk GD, Colberg M, Gesell MS, Dosescu J, Moshier JA (1994) Neuropeptide Y (NPY) enhances proliferation of human colonic lamina propria lymphocytes. Neuropeptides 26:289–295
Ericsson A, Schalling M, Mclntyre KR, Lundberg JM, Larhammar D, Seroogy K, Hökfelt T, Persson H (1987) Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc Natl Acad Sci USA 84:5585–5589
Ericsson A, Hemsen A, Lundberg JM, Persson H (1991) Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp Cell Res 192:604–611
Eruklar SD (1994). Molecular, cellular and medical aspects. In: Siegel G, Albers J, Agranoff BW, Albers R, Molinoff PB (eds) Basic Neurochemistry. Raven Press, New York, pp 181-208
Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S (1985) Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135:S755–S765.
Fink T, Weihe E (1988) Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation? Neurosci Lett 90:39–44
Fiore M, Angelucci F, Alleva E, Branchi I, Probert L, Aloe L (2000) Learning performances, brain NGF distribution and NPY levels in transgenic mice expressing TNFalpha. Behav Brain Res 112:165–175
Fried G, Terenius L, Hökfelt T, Goldstein M (1985) Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. J Neurosci 5:450–458
Friedman EM, Irwin MR, Nonogaki K (1995) Neuropeptide Y inhibits in vivo specific antibody production in rats. Brain Behav Immun 9:182–189
Furukawa F (1997) Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity. Lupus 6:193–202
Gallai V, Sarchielli P, Firenze C, Trequattrini A, Paciaroni M, Usai F, Franceschini M, Palumbo R (1994) Neuropeptide Y plasma levels and serum dopamine-beta-hydroxylase activity in MS patients with and without abnormal cardiovascular reflexes. Acta Neurol Belg 94:44–52
Gehlert DR, Gackenheimer SL (1996) Unexpected high density of neuropeptide Y Y1 receptors in the guinea pig spleen. Peptides 17:1345–1348
Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 5:170–175
Gluck T, Oertel M, Reber T, Zietz B, Schölmerich J, Straub RH (2000) Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. I. The hypothalamus-autonomic nervous system axis. J Rheumatol 27:903–910
Goebels N, Hofstetter H, Schmidt S, Brunner C, Wekerle H, Hohlfeld R (2000) Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain 123(3):508–518
Grau V, Scriba A, Stehling O, Steiniger B (2000) Monocytes in the rat. Immunobiology 202:94–103
Hafström I, Ringertz B, Lundeberg T, Palmblad J (1993) The effect of endothelin, neuropeptide Y, calcitonin gene-related peptide and substance P on neutrophil functions. Acta Physiol Scand 148:341–346
Hampton MB, Kettle AJ, Winterbourn CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92:3007–3017
Hauser GJ, Myers AK, Dayao EK, Zukowska-Grojec Z (1993) Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock. Am J Physiol 265:H1416–H1423
Hernanz A, Tato E, De la F M, de Miguel E, Arnalich F (1996) Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects. J Neuroimmunol 71:25–30
Herzenberg LA (2000) B-l cells: the lineage question revisited. Immunol Rev 175:9–22
Higuchi T, Aiba Y, Nomura T, Matsuda J, Mochida K, Suzuki M, Kikutani H, Honjo T, Nishioka K, Tsubata T (2002) Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 168:9–12
Holmlund A, Ekblom A, Hansson P, Lind J, Lundeberg T, Theodorsson E (1991) Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthroscopic findings. Int J Oral Maxillofac Surg 20:228–231
Hori T, Katafuchi T, Take S, Shimizu N, Niijima A (1995) The autonomic nervous system as a communication channel between the brain and the immune system. Neuroimmunomodulation 2:203–215
Hökfelt T (1991) Neuropeptides in perspective: the last ten years. Neuron 7:867–879
Huck S, Le Corre R, Youinou P, Zouali M (2001) Expression of B cell receptor-associated signaling molecules in human lupus. Autoimmunity 33:213–224
Irwin M, Daniels M, Bloom E T, Smith T L, Weiner H (1987) Life events, depressive symptoms, and immune function. Am J Psychiatry 144:437–441
Irwin M, Brown M, Patterson T, Hauger R, Mascovich A, Grant I (1991) Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J 5:3100–3107
Jacobs R, Pawlak CR, Mikeska E, Meyer-Olson D, Martin M, Heijnen CJ, Schedlowski M, Schmidt RE (2001) Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology (Oxford) 40:868–875
Jarek MJ, Legare EJ, McDermott MT, Merenich JA, Kollef MH (1993) Endocrine profiles for outcome prediction from the intensive care unit. Crit Care Med 21:543–550
Jindal N, Hollenberg SM, Dellinger RP (2000) Pharmacologic issues in the management of septic shock. Crit Care Clin 16:233–249
Jones BM, Cheng IK, Wong RW, Kung AW (1993) CD5-positive and CD5-negative rheumatoid factor-secreting B cells in IgA nephropathy, rheumatoid arthritis and Graves’ disease. Scand J Immunol 38:575–580
Karaszewski JW, Reder AT, Anlar B, Arnason GW (1993) Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J Neuroimmunol 43:1–7
Katafuchi T, Ichijo T, Take S, Hori T (1993) Hypothalamic modulation of splenic natural killer cell activity in rats. J Physiol 471:209–221
Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H (1998) Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5:9–15
Kiecolt-Glaser JK, Ricker D, George J, Messick G, Speicher CE, Garner W, Glaser R (1984) Urinary Cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom Med 46:15–23
Kodukula K, Arcuri M, Cutrone JQ, Hugill RM, Lowe SE, Pirnik DM, Shu YZ, Fernandes PB, Seethala R (1995) BMS-192548, a tetracyclic binding inhibitor of neuropeptide Y receptors, from Aspergillus niger WB2346. I. Taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) 48:1055–1059
Kohm AP, Sanders VM (2001) Norepinephrine and Beta2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53:487–525
Konttinen YT, Hukkanen M, Kemppinen P, Segerberg M, Sorsa T, Malmstrom M, Rose S, Itescu S, Polak JM (1992) Peptide-containing nerves in labial salivary glands in Sjogren’s syndrome. Arthritis Rheum 35:815–820
Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodorsson E (1991) Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol 20:326–335
Lehmann D, Karussis D, Mizrachi-Koll R, Linde A S, Abramsky O (1997) Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+/CD45RA+ cells and downregulation of CD4+/CD45RO+ cells. Clin Immunol Immunopathol 85:202–209
Levine JD, Collier DH, Basbaum Al, Moskowitz MA, Helms CA (1985) Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 12:406–411
Levite M (1998a) Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 95:12544–12549
Levite M, Cahalon L, Hershkoviz R, Steinman L, Lider O (1998b) Neuropeptides, via specific receptors, regulate Tcell adhesion to fibronectin. J Immunol 160:993–1000
Lorton D, Lubahn C, Klein N, Schaller J, Bellinger DL (1999) Dual role for noradrenergic innervation of lymphoid tissue and arthritic joints in adjuvant-induced arthritis. Brain Behav Immun 13:315–334
Lundberg JM, Saria A, Franco-Cereceda A, Theodorsson-Norheim E (1985) Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs. Acta Physiol Scand 124:603–611
Lundberg JM, Rudehill A, Sollevi A, Fried G, Wallin G (1989) Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience 28:475–486
Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48:113–178
Madden KS (2001) Catecholamines, sympathetic nerves, and immunity. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology. Academic Press, San Diego, pp 197–230
Maeda K, Yasuda M, Kaneda H, Maeda S, Yamadori A (1994) Cerebrospinal fluid (CSF) neuropeptide Y-and somatostatin-like immunoreactivities in man. Neuropeptides 27:323–332
Malfait AM, Malik AS, Marinova-Mutafchieva L, Butler DM, Maini RN, Feldmann M (1999) The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J Immunol 162:6278–6283
Malmström RE, Hökfelt T, Bjorkman JA, Nihlen C, Bystrom M, Ekstrand AJ, Lundberg JM (1998) Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog. Regul Pept 75/76:55–70
Mapp PI, Kidd BL, Gibson SJ, Terry JM, Revell PA, Ibrahim NB, Blake DR, Polak JM (1990) Substance P-, calcitonin gene-related peptide-and c-flanking peptide of neuropeptide Y ir-fibers are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 37:143–153
Medina S, Del Rio M, Hernanz A, de la Fuente M (2000) Age-related changes in the neuropeptide Y effects on murine lymphoproliferation and interleukin-2 production. Peptides 21:1403–1409
Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (1998) XVI. International Union of Pharmacology recommend dations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143–150
Miles K, Quintans J, Chelmicka-Schorr E, Arnason BG (1981) The sympathetic nervous system modulates antibody response to thymus-independent antigens. J Neuroimmunol 1:101–105
Miller LE, Justen HP, Schölmerich J, Straub RH (2000) The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 14:2097–2107
Mitchell B, Kendall M, Adam E, Schumacher U (1997) Innervation of the thymus in normal and bone marrow reconstituted severe combined immunodeficient (SCID) mice. J Neuroimmunol 75:19–27
Mor A, Chartrel N, Vaudry H, Nicolas P (1994) Skin peptide tyrosine-tyrosine, a member of the pancreatic polypeptide family: isolation, structure, synthesis, and endocrine activity. Proc Natl Acad Sci USA 91:10295–10299
Nair MP, Schwartz SA, Wu K, Kronfol Z (1993) Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav Immun 7:70–78
Nakajima A, Sendo W, Tsutsumino M, Koseki Y, Ichikawa N, Akama H, Taniguchi A, Terai C, Hara M, Kashiwazaki S (1998) Acute sympathetic hyperfunction in overlapping syndromes of systemic lupus erythematosus and polymyositis. J Rheumatol 25:1638–1641
Nawa H, Nakanishi S, Patterson PH (1991) Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotype by alterations in the size and amounts of neuropeptide mRNAs. J Neurochem 56:2147–2150
Neumann H, Medana I M, Bauer J, Lassmann H (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 25:313–319
Nordenbo AM, Boesen F, Andersen EB (1989) Cardiovascular autonomic function in multiple sclerosis. J Auton Nerv Syst 26:77–84
Ohia SE, Jumblatt JE (1990) Inhibitory effects of neuropeptide Y on sympathetic neurotransmission in the rabbit iris-ciliary body. Neurochem Res 15:251–256
Panina-Bordignon P, Mazzeo D, Lucia PD, D’Ambrosio D, Lang R, Fabbri L, Self C, Sinigaglia F (1997) Beta2-agonists prevent Thl development by selective inhibition of interleukin 12. J Clin Invest 100:1513–1519
Parnet P, Kelley KW, Bluthe RM, Dantzer R (2002) Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J Neuroimmunol 125:5–14
Paul WE (1998) Fundamental Immunology, Lippincott-Raven, New York, p 245
Pellieux C, Sauthier T, Domenighetti A, Marsh DJ, Palmiter RD, Brunner HR, Pedrazzini T (2000) Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc Natl Acad Sci USA 97:1595–1600
Pereira da Silva JA, Carmo-Fonseca M (1990) Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol 17:1592–1599
Petitto JM, Huang Z, McCarthy DB (1994) Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. J Neuroimmunol 54:81–86
Reder A, Checinski M, Chelmicka-Schorr E (1989) The effect of chemical sympathectomy on natural killer cells in mice. Brain Behav Immun 3:110–118
Romano TA, Felten SY, Felten DL, Olschowka J A (1991) Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide. Brain Behav Immun 5:116–131
Sawchenko PE, Swanson LW (1982) The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 257:275–325
Schwarz H, Villiger PM, von Kempis J, Lotz M (1994) Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol 51:53–61
Scriba A, Schneider M, Grau V, van der Meide P H, Steiniger B (1997) Rat monocytes upregulate NKR-P1A and down-modulate CD4 and CD43 during activation in vivo: monocyte subpopulations in normal and IFN-gamma-treated rats. J Leukoc Biol 62:741–752
Sellebjerg F, Jensen J, Jensen C V, Wiik A (2002) Expansion of CD5-B cells in multiple sclerosis correlates with CD80 (B7-1) expression. Scand J Immunol 56:101–107
Severn A, Rapson NT, Hunter CA, Liew FY (1992) Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 148:3441–3445
Shen GH, Grundemar L, Zukowska-Grojec Z, Hakanson R, Wahlestedt C (1991) C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents. Eur J Pharmacol 204:249–256
Shimizu M, Shigeri Y, Tatsu Y, Yoshikawa S, Yumoto N (1998) Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation. Antimicrob Agents Chemother 42:2745–2746
Soder O Hellström PM (1987) Neuropeptide regulation of human thymocyte, guinea pig T lymphocyte and rat B lymphocyte mitogenesis. Int Arch Allergy Appl Immunol 84:205–211
Song C Leonard B E (1998) Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions. Eur J Pharmacol 345:79–87
Straub RH, Westermann J, Schölmerich J, Falk W (1998) Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today 19:409–413
Straub RH, Schaller T, Miller LE, von Hörsten S, Jessop DS, Falk W, Schölmerich J (2000a) Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay. J Neurochem 75:2464–2471
Straub RH, Mayer M, Kreutz M, Leeb S, Schölmerich J, Falk W (2000b) Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 67:553–558
Straub RH, Herfarth H, Falk W, Andus T, Schölmerich J (2002) Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? J Neuroimmunol 126:116–125
Sung CP, Arleth AJ, Feuerstein GZ (1991) Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. Circ Res 68:314–318
Tabarowski Z, Gibson-Berry K, Felten SY (1996) Noradrenergic and peptidergic innervation of the mouse femur bone marrow. Acta Histochem 98:453–457
Thyaga Rajan S, Felten SY, Felten DL (1998) Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of L-deprenyl treatment in young sympathectomized and old Fischer 344 rats. J Neuroimmunol 81:144–157
Turnbull AV Rivier CL (1999) Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79:1–71
van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF (1996) Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97:713–719
van Roon JA, Lafeber FP, Bijlsma JW (2001) Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum 44:3–12
Vermeer LA, de Boer NK, Bucci C, Bos NA, Kroese FG, Alberti S (1994) MRC OX19 recognizes the rat CD5 surface glycoprotein, but does not provide evidence for a population of CD5bright B cells. Eur J Immunol 24:585–592
von Horsten S, Nave H, Ballof J, Helfritz F, Meyer D, Schmidt RE, Stalp M, Exton NG, Exton MS, Straub RH, Radulovic J, Pabst R (1998a) Centrally applied NPY mimics immunoactivation induced by non-analgesic doses of met-enkephalin. Neuroreport 9:3881–3885
von Hörsten S, Ballof J, Helfritz F, Nave H, Meyer D, Schmidt RE, Stalp M, Klemm A, Tschernig T, Pabst R (1998b) Modulation of innate immune functions by intracerebroventricularly applied neuropeptide Y: dose and time dependent effects. Life Sci 63:909–922
von Hörsten S, Exton NG, Exton MS, Helfritz F, Nave H, Ballof J, Stalp M, Pabst R (1998c) Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen. Brain Res 806:282–286
Vouldoukis I, Shai Y, Nicolas P, Mor A (1996) Broad spectrum antibiotic activity of the skin-PYY. FEBS Lett 380:237–240
Wahlestedt C, Edvinsson L, Ekblad E, Hakanson R (1985) Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 234:735–741
Westermann J, Pabst R (1990) Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today 11:406–410
Westermann J, Michel S, Lopez-Kostka S, Bode U, Rothkötter HJ, Bette M, Weihe E, Straub RH, Pabst R (1998) Regeneration of implanted splenic tissue in the rat: re-innervation is host age-dependent and necessary for tissue development. J Neuroimmunol 88:67–76
Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, Glockner F, Lanksch WR, Volk HD, Docke WD (1998) Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nature Med 4:808–813
Xu Y Wiernik PH (2001) Systemic lupus erythematosus and B-cell hematologic neoplasm. Lupus 10:841–850
Yang D, Biragyn A, Kwak LW, Oppenheim JJ (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 23:291–296
Yokota T, Matsunaga T, Okiyama R, Hirose K, Tanabe H, Furukawa T, Tsukagoshi H (1991) Sympathetic skin response in patients with multiple sclerosis compared with patients with spinal cord transection and normal controls. Brain 114(3):1381–1394
Zoukos Y, Thomaides T, Pavitt DV, Leonard JP, Cuzner ML, Mathias CJ (1992) Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects. Clin Auton Res 2:165–170
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bedoui, S., Pabst, R., von Hörsten, S. (2004). NPY and Immune Functions: Implications for Health and Disease. In: Michel, M.C. (eds) Neuropeptide Y and Related Peptides. Handbook of Experimental Pharmacology, vol 162. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18764-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-18764-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62282-3
Online ISBN: 978-3-642-18764-3
eBook Packages: Springer Book Archive